Vitamin D as a neuroactive substance: Review

被引:93
作者
Kiraly, Stephen J. [1 ]
Kiraly, Michael A.
Hawe, Rick D.
Makhani, Naila
机构
[1] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
来源
THESCIENTIFICWORLDJOURNAL | 2006年 / 6卷
关键词
brain-derived neurotrophic factors (BDNF); calcidiol; calciferol; calcitriol; cholecalciferol; experimental autoimmune encephalitis (EAE); parathyroid hormone (PTH); vitamin D; nerve growth factor (NGF); nitric oxide;
D O I
10.1100/tsw.2006.25
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The objectives of this paper were (1) to review recent research on the actions of vitamin D as a steroid derivative with neuroactive properties and (2) to highlight clinical relevance and need for more research. Our methods included review of research from current journals, Medline, and Cochrane Reviews; theoretical discussion. Scientific research has had a justifiably strong emphasis on how vitamin D affects calcium metabolism and bone. This appears to have eclipsed its fundamental actions on several other important systems, including the central nervous system. Vitamin D as a neuroactive compound, a prohormone, is highly active in regulating cell differentiation, proliferation, and peroxidation in a variety of structures, including the brain. Vitamin D insufficiency is not rare. Historically, focus has been on bone metabolism, which appears to have caused research bias and evidence bias, distorting physiological importance. The central nervous system is increasingly recognized as a target organ for vitamin D via its wide-ranging hormonal effects, including the induction of proteins such as nerve growth factor. We need more research on this important neuroactive substance because it may play a role as a relatively safe and inexpensive pharmaceutical in the prevention and treatment of a number of common neuropsychiatric conditions.
引用
收藏
页码:125 / 139
页数:15
相关论文
共 155 条
[91]   Redefining vitamin D insufficiency [J].
Malabanan, A ;
Veronikis, IE ;
Holick, MF .
LANCET, 1998, 351 (9105) :805-806
[92]   Severe generalized bone pain and osteoporosis in a premenopausal black female:: Effect of vitamin D replacement [J].
Malabanan, AO ;
Turner, AK ;
Holick, MF .
JOURNAL OF CLINICAL DENSITOMETRY, 1998, 1 (02) :201-204
[93]   FAMILIAL IDIOPATHIC STRIO-PALLIDO-DENTATE CALCIFICATIONS WITH LATE ONSET EXTRAPYRAMIDAL SYNDROME [J].
MARTINELLI, P ;
GIULIANI, S ;
IPPOLITI, M ;
MARTINELLI, A ;
SFORZA, A ;
FERRARI, S .
MOVEMENT DISORDERS, 1993, 8 (02) :220-222
[94]   SUNSCREENS SUPPRESS CUTANEOUS VITAMIN-D3 SYNTHESIS [J].
MATSUOKA, LY ;
IDE, L ;
WORTSMAN, J ;
MACLAUGHLIN, JA ;
HOLICK, MF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06) :1165-1168
[95]   CHRONIC SUNSCREEN USE DECREASES CIRCULATING CONCENTRATIONS OF 25-HYDROXYVITAMIN-D - A PRELIMINARY-STUDY [J].
MATSUOKA, LY ;
WORTSMAN, J ;
HANIFAN, N ;
HOLICK, MF .
ARCHIVES OF DERMATOLOGY, 1988, 124 (12) :1802-1804
[96]   CLOTHING PREVENTS ULTRAVIOLET-B RADIATION-DEPENDENT PHOTOSYNTHESIS OF VITAMIN-D3 [J].
MATSUOKA, LY ;
WORTSMAN, J ;
DANNENBERG, MJ ;
HOLLIS, BW ;
LU, ZR ;
HOLICK, MF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (04) :1099-1103
[97]   Vitamin D supplementation during the first year of life and risk of schizophrenia:: a Finnish birth cohort study [J].
McGrath, J ;
Saari, K ;
Hakko, H ;
Jokelainen, J ;
Jones, P ;
Järvelin, MR ;
Chant, D ;
Isohanni, M .
SCHIZOPHRENIA RESEARCH, 2004, 67 (2-3) :237-245
[98]   Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? [J].
McGrath, J .
MEDICAL HYPOTHESES, 2001, 56 (03) :367-371
[99]   Vitamin D: the neglected neurosteroid? [J].
McGrath, J ;
Feron, F ;
Eyles, D ;
Mackay-Sim, A .
TRENDS IN NEUROSCIENCES, 2001, 24 (10) :570-571
[100]   Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? [J].
McGrath, J .
SCHIZOPHRENIA RESEARCH, 1999, 40 (03) :173-177